Detalles de la búsqueda
1.
Texture analysis of 18F-FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement.
Hematol Oncol
; 42(2): e3261, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38454623
2.
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.
Br J Haematol
; 201(4): 653-662, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36733229
3.
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Haematologica
; 108(4): 1083-1091, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36384247
4.
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Hematol Oncol
; 41(1): 78-87, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36177902
5.
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network).
Ann Hematol
; 102(4): 841-849, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36735074
6.
Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression.
Histopathology
; 80(2): 430-442, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33948980
7.
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study).
Hematol Oncol
; 40(4): 609-616, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35612350
8.
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the "RTL" (Regional Tuscan Lymphoma network).
Eur J Haematol
; 108(5): 383-390, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35051301
9.
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL).
Br J Haematol
; 193(2): 280-289, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33476434
10.
Treatment and prognosis of primary pulmonary lymphoma: A long-term follow-up study.
Eur J Haematol
; 106(1): 49-57, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32779796
11.
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study.
Ann Hematol
; 99(2): 283-291, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31872361
12.
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments.
Ann Hematol
; 99(2): 277-282, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31872362
13.
Primary pulmonary lymphoma: imaging findings in 30 cases.
Radiol Med
; 124(12): 1262-1269, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31583557
14.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica
; 102(11): 1931-1935, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28775121
15.
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments.
Ann Hematol
; 100(1): 303-304, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33219839
16.
Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.
Br J Haematol
; 169(4): 544-51, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25817296
17.
The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).
Am J Hematol
; 90(6): 499-503, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25720750
18.
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi.
Am J Hematol
; 90(1): 56-61, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25327841
19.
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
Br J Haematol
; 185(5): 940-944, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30407625
20.
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP.
Blood
; 119(9): 2066-73, 2012 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22234681